Quarterly report · Q2
4885.TEDINET S100PYKH
Period2022-06-01 → 2022-11-30
Filed2023-01-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 51
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.1bn | 2022-06-01 → 2022-11-30 | Standalone | Net sales |
| Revenue | ¥5.7bn | 2021-06-01 → 2022-05-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.8bn | 2021-06-01 → 2021-11-30 | Standalone | Net sales |
| Operating income | ¥225m | 2022-06-01 → 2022-11-30 | Standalone | Operating income |
| Operating income | ¥323m | 2021-06-01 → 2021-11-30 | Standalone | Operating income |
| Ordinary income | ¥208m | 2022-06-01 → 2022-11-30 | Standalone | Ordinary income |
| Ordinary income | ¥423m | 2021-06-01 → 2022-05-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥324m | 2021-06-01 → 2021-11-30 | Standalone | Ordinary income |
| Profit before tax | ¥208m | 2022-06-01 → 2022-11-30 | Standalone | Income before income taxes |
| Profit before tax | ¥324m | 2021-06-01 → 2021-11-30 | Standalone | Income before income taxes |
| Net income | ¥149m | 2022-06-01 → 2022-11-30 | Standalone | Profit loss |
| Net income | ¥456m | 2021-06-01 → 2022-05-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥262m | 2021-06-01 → 2021-11-30 | Standalone | Profit loss |
| Total assets | ¥5.0bn | at 2022-11-30 | Standalone | Assets |
| Total assets | ¥4.8bn | at 2022-05-31 | Standalone | Assets |
| Total assets | ¥4.5bn | at 2021-11-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.2bn | at 2022-11-30 | Standalone | Liabilities |
| Total liabilities | ¥3.1bn | at 2022-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.8bn | at 2022-11-30 | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.6bn | at 2021-11-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥765m | at 2022-11-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥865m | at 2022-05-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥765m | at 2022-11-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥865m | at 2022-05-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥839m | at 2021-11-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2021-05-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥58m | 2022-06-01 → 2022-11-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥525m | 2021-06-01 → 2022-05-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥152m | 2021-06-01 → 2021-11-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥69m | 2022-06-01 → 2022-11-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥176m | 2021-06-01 → 2022-05-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥56m | 2021-06-01 → 2021-11-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥28m | 2022-06-01 → 2022-11-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥484m | 2021-06-01 → 2022-05-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥257m | 2021-06-01 → 2021-11-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥39.92 | 2022-06-01 → 2022-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.8 | 2022-09-01 → 2022-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.79 | 2021-06-01 → 2022-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥71.35 | 2021-06-01 → 2021-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.97 | 2021-09-01 → 2021-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥38.62 | 2022-06-01 → 2022-11-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥112.56 | 2021-06-01 → 2022-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥64.36 | 2021-06-01 → 2021-11-30 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥19 | 2021-06-01 → 2022-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 35.8% | at 2022-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.0% | at 2022-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.6% | at 2021-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 4,095,500 | at 2022-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2022-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2021-11-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥965m |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥965m |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | segment profit | 2022-06-01 → 2022-11-30 | −¥20m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥377m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥377m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | segment profit | 2022-06-01 → 2022-11-30 | −¥39m |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥1.8bn |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥1.8bn |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥284m |
| —segment total | revenue | 2022-06-01 → 2022-11-30 | ¥3.1bn |
| —segment total | revenue external | 2022-06-01 → 2022-11-30 | ¥3.1bn |
| —segment total | segment profit | 2022-06-01 → 2022-11-30 | ¥225m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-11-30 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-11-30 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-11-30 | ¥225m |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥956m |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥956m |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥5m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥488m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥488m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥40m |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥278m |
| —segment total | revenue | 2021-06-01 → 2021-11-30 | ¥2.8bn |
| —segment total | revenue external | 2021-06-01 → 2021-11-30 | ¥2.8bn |
| —segment total | segment profit | 2021-06-01 → 2021-11-30 | ¥323m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2021-11-30 | ¥2.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2021-11-30 | ¥2.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2021-11-30 | ¥323m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 495
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of intangible assets inv cf | CurrentYTDDuration_NonConsolidatedMember | -30700000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration_NonConsolidatedMember | -1040000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration_NonConsolidatedMember | -1076000 | JPY |
| Payments for lease and guarantee deposits inv cf | Prior1YTDDuration_NonConsolidatedMember | -712000 | JPY |
| Payments for lease and guarantee deposits inv cf | CurrentYTDDuration_NonConsolidatedMember | -243000 | JPY |
| Other net inv cf | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Other net inv cf | CurrentYTDDuration_NonConsolidatedMember | -1383000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration_NonConsolidatedMember | -56362000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration_NonConsolidatedMember | -69475000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration_NonConsolidatedMember | -100000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration_NonConsolidatedMember | -100000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration_NonConsolidatedMember | 300000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration_NonConsolidatedMember | -101240000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration_NonConsolidatedMember | -101240000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration_NonConsolidatedMember | -828000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration_NonConsolidatedMember | -419000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration_NonConsolidatedMember | -42000 | JPY |
| Proceeds from exercise of stock option fin cf | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Proceeds from exercise of stock option fin cf | CurrentYTDDuration_NonConsolidatedMember | 310000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration_NonConsolidatedMember | -54982000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration_NonConsolidatedMember | -70544000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration_NonConsolidatedMember | -257050000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration_NonConsolidatedMember | 28064000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration_NonConsolidatedMember | -161725000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration_NonConsolidatedMember | -99909000 | JPY |
| Cash and cash equivalents | Prior2YearInstant_NonConsolidatedMember | 1000373000 | JPY |
| Cash and cash equivalents | Prior1YearInstant_NonConsolidatedMember | 865361000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant_NonConsolidatedMember | 838647000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant_NonConsolidatedMember | 765452000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000PharmaceuticalBusinessReportableSegmentMember | 1363729000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000HealthyFoodBusinessReportableSegmentMember | 487989000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000ChemicalProductsBusinessReportableSegmentMember | 956228000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 2807947000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 2807947000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember | 2807947000 | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000PharmaceuticalBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000HealthyFoodBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000ChemicalProductsBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000PharmaceuticalBusinessReportableSegmentMember | 1363729000 | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000HealthyFoodBusinessReportableSegmentMember | 487989000 | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000ChemicalProductsBusinessReportableSegmentMember | 956228000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |